Annacor had prediction of peak sale of $2bil per annum. Annacor was paid 2.5x their peak sales. obviously patient lengths come in to play, market size and lots of other factors.
we are predicted to be $950m per annum peak sales going by the euroz report. that is with a 3% market share from the 3.7m patients. doesn't include the broader market that would also use this product.
articles I have read suggest there can be a lot of variables but often a 10% market share for a best in class is probably not unreasonable and to base your figures off for valuations. So call it $2bil per annum peak sales being conservative which is 6-7% market share. maybe we could get a similar price to Annacor.
$5.2bil usd = $5.2 a share for us.
please vinnie I hope you are reading these same articles about about how to value your biotech company
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-7664
-
- There are more pages in this discussion • 8,156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.025(7.25%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
35.0¢ | 35.0¢ | 32.0¢ | $1.732M | 5.231M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 413440 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 46819 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 407190 | 0.320 |
9 | 191457 | 0.315 |
21 | 694831 | 0.310 |
9 | 420204 | 0.305 |
28 | 358280 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 46819 | 2 |
0.330 | 159394 | 2 |
0.335 | 287286 | 6 |
0.340 | 218507 | 3 |
0.345 | 143022 | 3 |
Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |